TABLE 4.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
Odds ratio | Confidence interval | P | Odds ratio | Confidence interval | P | |
Age | 0.992 | 0.931‐1.058 | .812 | |||
Male sex | 1.588 | 0.236‐10.704 | .635 | |||
Post‐transplant time | 0.996 | 0.98‐1.012 | .638 | |||
Deceased donor | 0.516 | 0.046‐5.84 | .593 | |||
ATLG usage as an induction therapy | 1.83 | 0.522‐6.413 | .345 | |||
Usage of cyclosporine | 0.167 | 0.065‐0.43 | <.001 | 0.077 | 0.018‐0.324 | <.001 |
Anti‐rejection therapy | 11.625 | 1.467‐92.139 | .02 | 9.75 | 1.223‐77.724 | .032 |
SpO2 value | 0.915 | 0.723‐1.158 | .46 | |||
Serum LDH levels | 1.006 | 0.098‐1.014 | .052 | |||
Serum ALT levels | 1.009 | 0.974‐1.045 | .622 | |||
Graft dysfunction at admission | 0.538 | 0.051‐5.74 | .608 | |||
CNI withdrawal after admission | 0.198 | 0.028‐1.396 | .104 | |||
Anti‐viral treatment | 6 | 0.606‐59.444 | .126 | |||
Antibiotics | 0.13 | 0.013‐1.301 | .087 | |||
Anti‐cytokine agents | 0.31 | 0.042‐2.278 | .25 |
P‐values in bold showed statistically significant differences.
Abbreviations: ALT, alanine aminotransferase; ATLG, anti‐T‐lymphocyte globulin; CNI, calcineurin inhibitors; LDH, lactate dehydrogenase; RT‐PCR, reverse transcription‐polymerase chain reaction; SpO2, blood oxygen saturation levels.